4Filed Sep 9, 8:00 PM ET

Procter & Gamble (PG) Director Christopher J. Kempczinski Receives Award

$PG · PROCTER & GAMBLE Co

Research Summary

AI-generated summary of this SEC filing

Updated

Procter & Gamble (PG) Director Christopher J. Kempczinski Receives Award

What Happened
Christopher J. Kempczinski, a director of Procter & Gamble Co. (PG), was granted 250 restricted stock units (RSUs) on September 8, 2026. The Form 4 reports an acquisition at $0.00 per share (code A), i.e., these were an award of RSUs rather than an open‑market purchase or sale. Footnotes indicate the award was made under The Procter & Gamble 2025 Stock and Incentive Compensation Plan and includes dividend equivalents credited as RSUs.

Key Details

  • Transaction date: 2026-09-08; Form 4 filed: 2026-09-10 (filed two days later; appears timely).
  • Transaction type/code: A (award/grant of RSUs).
  • Quantity and price: 250 RSUs reported at $0.00; Form 4 shows total acquisition value as $0.
  • Shares owned after transaction: Not specified in this filing.
  • Footnotes: F1 — RSUs awarded pursuant to the 2025 Stock and Incentive Compensation Plan. F2 — total includes grant of dividend equivalents in the form of RSUs.
  • No indication of a 10b5-1 plan, tax withholding sale, or immediate cashless sale in this Form 4.

Context
RSUs are a form of compensation that typically convert to shares upon vesting; they do not represent an open‑market buy or sell and therefore are less directly informative about an insider’s short‑term market sentiment. Dividend equivalents paid as additional RSUs increase the award quantity but likewise reflect compensation policy. For monetary value, vesting schedule, or additional terms, check the company’s proxy statements or related 8‑K disclosures.